Treatment of corneal cystine crystal accumulation in patients with cystinosis

被引:37
|
作者
Shams, Fatemeh [1 ]
Livingstone, Iain [1 ]
Oladiwura, Dilys [1 ]
Ramaesh, Kanna [1 ]
机构
[1] Gartnavel Royal Hosp, Dept Ophthalmol, Great Western Roads, Glasgow G12 0YN, Lanark, Scotland
来源
CLINICAL OPHTHALMOLOGY | 2014年 / 8卷
关键词
cystinosis; cysteamine; cornea; ocular; crystals; lysosome;
D O I
10.2147/OPTH.S36626
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Cystinosis is a rare autosomal recessive disorder characterized by the accumulation of cystine within the cells of different organs. Infantile nephropathic cystinosis is the most common and severe phenotype. With the success of renal transplantation, these patients are now living longer and thus more long-term complications within different organs are becoming apparent. Ophthalmic manifestations range from corneal deposits of cystine crystals to pigmentary retinopathy. With increasing age, more severe ocular complications have been reported. Photophobia is a prominent symptom for patients. With prolonged survival and increasing age, this symptom, along with corneal erosions and blepharospasm, can become debilitating. This review revisits the basic pathogenesis of cystinosis, the ocular manifestations of the disease, and the treatment of corneal crystals.
引用
收藏
页码:2077 / 2084
页数:8
相关论文
共 50 条
  • [1] Cysteamine ophthalmic solution 0.44% for the treatment of corneal cystine crystals in cystinosis
    Nancy Huynh
    Gahl, William A.
    Bishop, Rachel J.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2013, 8 (04) : 341 - 345
  • [2] Corneal Densitometry to Assess the Corneal Cystine Deposits in Patients With Cystinosis
    Biswas, Susmito
    Alzahrani, Khaled
    Radhakrishnan, Hema
    CORNEA, 2023, 42 (03) : 313 - 319
  • [3] Corneal crystals in nephropathic cystinosis: Natural history and treatment with cysteamine eyedrops
    Gahl, WA
    Kuehl, EM
    Iwata, F
    Lindblad, A
    Kaiser-Kupfer, MI
    MOLECULAR GENETICS AND METABOLISM, 2000, 71 (1-2) : 100 - 120
  • [4] Cystadrops® (cysteamine hydrochloride 0.55% viscous eye-drops solution) in treating corneal cystine crystal deposits in patients with cystinosis: a profile of its use
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2017, 33 (5) : 195 - 201
  • [5] Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis
    Levtchenko, EN
    van Dael, CM
    de Graaf-Hess, AC
    Wilmer, MJG
    van den Heuvel, LP
    Monnens, LA
    Blom, HJ
    PEDIATRIC NEPHROLOGY, 2006, 21 (01) : 110 - 113
  • [6] Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis
    Elena N. Levtchenko
    Carin M. van Dael
    Addy C. de Graaf-Hess
    Martijn J. G. Wilmer
    Lambertus P. van den Heuvel
    Leo A. Monnens
    Henk J. Blom
    Pediatric Nephrology, 2006, 21 : 110 - 113
  • [7] A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: The Cystadrops OCT-1 study
    Labbe, Antoine
    Baudouin, Christophe
    Deschenes, Georges
    Loirat, Chantal
    Charbit, Marina
    Guest, Genevieve
    Niaudet, Patrick
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (03) : 314 - 320
  • [8] Potential role of stromal collagen in cystine crystallization in cystinosis patients
    Dixon, Phillip
    Christopher, Keith
    Chauhan, Anuj
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 551 (1-2) : 232 - 240
  • [9] A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis
    Iwata, F
    Kuehl, EM
    Reed, GF
    McCain, LM
    Gahl, WA
    Kaiser-Kupfer, MI
    MOLECULAR GENETICS AND METABOLISM, 1998, 64 (04) : 237 - 242
  • [10] Corneal Manifestation in Patients with Infantile Nephropathic Cystinosis
    Kruse, Franziska
    Keidel, Leonie Franziska
    Priglinger, Siegfried
    Luft, Nikolaus
    Priglinger, Claudia
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2023, 240 (03) : 260 - 265